Amal Ltd
Incorporated in 1974, Amal Ltd manufactures bulk chemicals and their downstream products[1]
- Market Cap ₹ 896 Cr.
- Current Price ₹ 725
- High / Low ₹ 1,148 / 393
- Stock P/E 23.1
- Book Value ₹ 91.7
- Dividend Yield 0.14 %
- ROCE 36.3 %
- ROE 35.0 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
- Company is expected to give good quarter
- Company has delivered good profit growth of 27.6% CAGR over last 5 years
Cons
- Stock is trading at 7.88 times its book value
- Tax rate seems low
- Company has a low return on equity of 7.37% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Specialty Chemicals
Part of BSE SmallCap BSE Allcap BSE Commodities
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|
| 33 | 30 | 43 | 61 | 86 | 135 | 186 | |
| 19 | 19 | 40 | 67 | 71 | 92 | 135 | |
| Operating Profit | 14 | 11 | 4 | -6 | 15 | 44 | 51 |
| OPM % | 43% | 37% | 9% | -9% | 18% | 32% | 27% |
| 2 | 1 | 0 | 1 | 0 | 0 | 1 | |
| Interest | 2 | 1 | 1 | 4 | 4 | 2 | 1 |
| Depreciation | 1 | 1 | 2 | 7 | 9 | 9 | 9 |
| Profit before tax | 13 | 11 | 2 | -16 | 3 | 33 | 42 |
| Tax % | 28% | 19% | 31% | 3% | 39% | 10% | |
| 9 | 9 | 1 | -16 | 2 | 29 | 39 | |
| EPS in Rs | 7.41 | 7.10 | 0.90 | -13.03 | 1.38 | 23.69 | 31.36 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 4% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 33% |
| 3 Years: | 46% |
| TTM: | 91% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 28% |
| 3 Years: | 199% |
| TTM: | 350% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 37% |
| 5 Years: | 35% |
| 3 Years: | 34% |
| 1 Year: | 79% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 9% |
| 3 Years: | 7% |
| Last Year: | 35% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 9 | 9 | 9 | 12 | 12 | 12 | 12 |
| Reserves | 16 | 25 | 26 | 56 | 58 | 87 | 101 |
| 4 | 6 | 51 | 35 | 24 | 0 | 0 | |
| 4 | 8 | 14 | 15 | 13 | 22 | 25 | |
| Total Liabilities | 34 | 48 | 100 | 118 | 106 | 122 | 139 |
| 10 | 9 | 14 | 90 | 86 | 80 | 78 | |
| CWIP | 0 | 7 | 66 | 1 | 1 | 0 | 1 |
| Investments | 15 | 20 | 0 | 0 | 1 | 20 | 31 |
| 10 | 12 | 19 | 27 | 19 | 21 | 28 | |
| Total Assets | 34 | 48 | 100 | 118 | 106 | 122 | 139 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| 14 | 10 | -1 | -10 | 21 | 50 | |
| -5 | -11 | -43 | -16 | -9 | -22 | |
| -9 | 0 | 44 | 29 | -14 | -25 | |
| Net Cash Flow | 0 | 0 | -0 | 3 | -2 | 3 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| Debtor Days | 80 | 58 | 11 | 25 | 23 | 27 |
| Inventory Days | 38 | 53 | 34 | 26 | 28 | 33 |
| Days Payable | 97 | 120 | 42 | 31 | 36 | 68 |
| Cash Conversion Cycle | 21 | -10 | 4 | 21 | 15 | -9 |
| Working Capital Days | 49 | -12 | -51 | -41 | -6 | -11 |
| ROCE % | 33% | 4% | -12% | 7% | 36% |
Documents
Announcements
- Unaudited Standalone And Consolidated Financial Results With Limited Review Report For The Quarter / Six Months Ended September 30, 2025 15 Oct
-
Board Meeting Outcome for Unaudited Standalone And Consolidated Financial Results With Limited Review Report For The Quarter / Six Months Ended September 30, 2025
15 Oct - Q2/H1 ended Sep 30, 2025: Consolidated H1 revenue Rs10,222.70 lakh; PAT Rs1,546.15 lakh; limited review.
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 7 Oct
-
Closure of Trading Window
26 Sep - Board meeting Oct 15, 2025 to consider results for quarter/six months ended Sep 30; trading window Oct 1–17, 2025.
-
Board Meeting Intimation for Meeting Of The Board And Closure Of Trading Window
26 Sep - Board meets Oct 15, 2025 to consider unaudited results for period ended Sep 30; trading window closed Oct 1–17.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Business Overview:[1][2][3]
Amal, originally promoted by the Piramal Group, is now controlled by Atul Ltd, which holds a 49.86% stake through Atul Finserv Ltd. Registered as a small manufacturing company under the MSME Act, Amal produces bulk chemicals like sulphuric acid, oleum, and their derivatives. It also owns Amal Speciality Chemicals Ltd.